← Back to Search

Behavioral Intervention

Storytelling for Vaccine Hesitancy

N/A

Recruiting

Research Sponsored by University of Massachusetts, Worcester

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months after participation

Awards & highlights

Study Summary

"This trial will test a new storytelling method to address vaccine hesitancy among Black and Hispanic individuals in Central Massachusetts."

Who is the study for?

This trial is for Black and Hispanic individuals in Central Massachusetts who are hesitant to get the COVID-19 vaccine. Specific eligibility criteria details were not provided, so it's unclear who exactly can or cannot participate.Check my eligibility

What is being tested?

The study is testing a storytelling method against a 'Learn More' approach to see which one better reduces vaccine hesitancy among participants. It's an interactive, multimedia intervention based on community feedback.See study design

What are the potential side effects?

Since this trial focuses on educational interventions rather than medical treatments, there are no direct side effects from medications or vaccines being studied.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months after participation

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months after participation

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months after participation for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in Vaccine Hesitancy

Secondary outcome measures

Vaccine Uptake

Trial Design

2Treatment groups

Experimental Treatment

Group I: StorytellingExperimental Treatment1 Intervention

Participants will view short video narratives of community members speaking about why they chose to get vaccinated against Coronavirus Disease of 2019 (COVID-19) and how they overcame hesitancy. Participants will also view the informational videos described below.

Group II: Learn MoreExperimental Treatment1 Intervention

Participants will view short informational videos that provide factual information on the COVID-19 vaccines.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Storytelling

2018

N/A

~240

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Merck Sharp & Dohme LLCIndustry Sponsor

3,892 Previous Clinical Trials

5,061,096 Total Patients Enrolled

2 Trials studying Vaccine Hesitancy

178 Patients Enrolled for Vaccine Hesitancy

University of Massachusetts, WorcesterLead Sponsor

343 Previous Clinical Trials

986,560 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does the inclusion criteria for this medical study encompass individuals who are 60 years of age or older?

"Recruitment for this study is targeting individuals over 18 years but under the age of 105."

Answered by AI

What specific characteristics or criteria make an individual more suitable for inclusion in this clinical investigation?

"To be eligible for this research study, volunteers need to exhibit reluctance towards vaccination and fall within the age range of 18 to 105 years old. The trial aims to enroll a total of 50 participants."

Answered by AI

What is the current number of participants being recruited for this clinical study?

"Indeed, information from clinicaltrials.gov reveals that this investigation is actively seeking volunteers. Initially shared on May 19th, 2023, with the last update made on March 6th, 2024. The trial aims to enroll a total of 50 participants at one designated site."

Answered by AI

Are there any available positions for participants in this research study?

"Indeed, the details on clinicaltrials.gov confirm that this study is actively seeking participants. The trial was first listed on May 19th, 2023 and last updated on March 6th, 2024. Enrollment aims to include 50 patients at a single site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color

Jeroan Allison 2023. "COVIDVaxStories: Randomized Trial to Reduce COVID-19 Vaccine Hesitancy in Populations of Color". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06297876.

All > Paid Studies Boston